secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001193125-24-003926
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica updates company overview presentation; no material new data disclosed
-----------------------------------------------------------------------------

- Filing notes company presentation updated on website as of January 8, 2024.
- No specific financial, clinical, or operational metrics are provided in the exhibit.
- Presentation title slide only; substantive content not included in this filing.
- Furnished under Regulation FD, not incorporated by reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524003926/0001193125-24-003926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524003926/d109895d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer